DNA vaccines
- PMID: 9855413
DNA vaccines
Abstract
Immunization with plasmid DNA encoding antigenic proteins elicits both antibody and cell-mediated immune responses. This method of producing the protein antigens of interest directly in host cells can provide appropriate tertiary structure for the induction of conformationally specific antibodies, and also facilitates the induction of cellular immune responses. DNA immunization has provided effective protective immunity in various animal models. The immune responses induced by DNA vaccines may in some instances be preferable to those produced by immunization using conventional methods. DNA vaccination appears to be applicable to a variety of pathogens and is a useful method of raising immune responses. Thus this approach to vaccination has the potential to be a successful method of rapidly screening for antigens capable of inducing protective immunity, and of inducing protective immunity against pathogens of clinical importance.
Similar articles
-
DNA vaccines.Life Sci. 1997;60(3):163-72. doi: 10.1016/s0024-3205(96)00502-4. Life Sci. 1997. PMID: 9000640 Review.
-
[DNA vaccination].Praxis (Bern 1994). 2000 Oct 26;89(43):1745-8. Praxis (Bern 1994). 2000. PMID: 11103619 Review. German.
-
Designing immune responses with genetic immunization and immunostimulatory DNA sequences.Endocr Regul. 2001 Sep;35(3):143-66. Endocr Regul. 2001. PMID: 11674843 Review.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
Multiple-site DNA vaccination enhances immune responses in mice.Vaccine. 2006 Jan 16;24(3):287-92. doi: 10.1016/j.vaccine.2005.07.075. Epub 2005 Aug 8. Vaccine. 2006. PMID: 16137804
Cited by
-
Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d.J Virol. 2004 May;78(9):4710-9. doi: 10.1128/jvi.78.9.4710-4719.2004. J Virol. 2004. PMID: 15078953 Free PMC article.
-
Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.AIDS Res Hum Retroviruses. 2004 Nov;20(11):1259-68. doi: 10.1089/aid.2004.20.1259. AIDS Res Hum Retroviruses. 2004. PMID: 15588348 Free PMC article.
-
CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.J Virol. 2001 Jul;75(14):6482-91. doi: 10.1128/JVI.75.14.6482-6491.2001. J Virol. 2001. PMID: 11413315 Free PMC article.
-
Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.J Virol. 2002 Jan;76(1):243-50. doi: 10.1128/jvi.76.1.243-250.2002. J Virol. 2002. PMID: 11739689 Free PMC article.
-
Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.J Virol. 2003 Feb;77(3):2046-55. doi: 10.1128/jvi.77.3.2046-2055.2003. J Virol. 2003. PMID: 12525639 Free PMC article.